annual accounts payable:
$122.30M-$22.30M(-15.42%)Summary
- As of today (May 29, 2025), BIO annual accounts payable is $122.30 million, with the most recent change of -$22.30 million (-15.42%) on December 31, 2024.
- During the last 3 years, BIO annual accounts payable has fallen by -$19.64 million (-13.84%).
- BIO annual accounts payable is now -17.65% below its all-time high of $148.51 million, reached on December 31, 2013.
Performance
BIO Accounts payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly accounts payable:
$137.90M+$15.60M(+12.76%)Summary
- As of today (May 29, 2025), BIO quarterly accounts payable is $137.90 million, with the most recent change of +$15.60 million (+12.76%) on March 31, 2025.
- Over the past year, BIO quarterly accounts payable has increased by +$35.15 million (+34.21%).
- BIO quarterly accounts payable is now -50.83% below its all-time high of $280.45 million, reached on September 30, 2016.
Performance
BIO quarterly accounts payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
BIO Accounts payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -15.4% | +34.2% |
| 3 y3 years | -13.8% | -14.2% |
| 5 y5 years | +14.3% | +16.6% |
BIO Accounts payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -15.4% | at low | -14.3% | +34.2% |
| 5 y | 5-year | -15.4% | +14.3% | -14.3% | +34.2% |
| alltime | all time | -17.6% | +732.0% | -50.8% | +1030.3% |
BIO Accounts payable History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $137.90M(+12.8%) |
| Dec 2024 | $122.30M(-15.4%) | $122.30M(+0.1%) |
| Sep 2024 | - | $122.19M(-3.6%) |
| Jun 2024 | - | $126.69M(+23.3%) |
| Mar 2024 | - | $102.75M(-28.9%) |
| Dec 2023 | $144.60M(+7.1%) | $144.60M(+29.3%) |
| Sep 2023 | - | $111.86M(-25.2%) |
| Jun 2023 | - | $149.53M(-7.1%) |
| Mar 2023 | - | $160.98M(+19.2%) |
| Dec 2022 | $135.04M(-4.9%) | $135.04M(-5.4%) |
| Sep 2022 | - | $142.75M(-9.8%) |
| Jun 2022 | - | $158.26M(-1.5%) |
| Mar 2022 | - | $160.65M(+13.2%) |
| Dec 2021 | $141.94M(+1.8%) | $141.94M(+4.1%) |
| Sep 2021 | - | $136.40M(+2.2%) |
| Jun 2021 | - | $133.46M(-3.6%) |
| Mar 2021 | - | $138.49M(-0.7%) |
| Dec 2020 | $139.45M(+30.3%) | $139.45M(+4.9%) |
| Sep 2020 | - | $132.99M(+1.6%) |
| Jun 2020 | - | $130.91M(+10.7%) |
| Mar 2020 | - | $118.22M(+10.5%) |
| Dec 2019 | $107.01M(-12.6%) | $107.01M(-57.2%) |
| Sep 2019 | - | $249.84M(+1.2%) |
| Jun 2019 | - | $246.81M(+3.3%) |
| Mar 2019 | - | $239.02M(+95.2%) |
| Dec 2018 | $122.45M(-9.4%) | $122.45M(-52.4%) |
| Sep 2018 | - | $257.03M(-1.8%) |
| Jun 2018 | - | $261.72M(+0.9%) |
| Mar 2018 | - | $259.37M(+91.9%) |
| Dec 2017 | $135.18M(+1.6%) | $135.18M(-50.7%) |
| Sep 2017 | - | $273.96M(-1.3%) |
| Jun 2017 | - | $277.57M(+19.9%) |
| Mar 2017 | - | $231.49M(+73.9%) |
| Dec 2016 | $133.11M(+3.5%) | $133.11M(-52.5%) |
| Sep 2016 | - | $280.45M(+9.5%) |
| Jun 2016 | - | $256.11M(+6.2%) |
| Mar 2016 | - | $241.25M(-10.1%) |
| Sep 2015 | - | $268.23M(+11.8%) |
| Jun 2015 | - | $239.85M(-4.4%) |
| Mar 2015 | - | $250.81M(+95.0%) |
| Dec 2014 | $128.61M(-13.4%) | $128.61M(+1.6%) |
| Sep 2014 | - | $126.64M(+0.9%) |
| Jun 2014 | - | $125.46M(-4.1%) |
| Mar 2014 | - | $130.86M(-11.9%) |
| Dec 2013 | $148.51M(+13.5%) | $148.51M(+12.6%) |
| Sep 2013 | - | $131.90M(+2.2%) |
| Jun 2013 | - | $129.12M(+8.2%) |
| Mar 2013 | - | $119.34M(-8.8%) |
| Dec 2012 | $130.87M(+1.3%) | $130.87M(+15.5%) |
| Sep 2012 | - | $113.28M(-5.2%) |
| Jun 2012 | - | $119.45M(+9.0%) |
| Mar 2012 | - | $109.57M(-15.1%) |
| Dec 2011 | $129.12M(+13.8%) | $129.12M(+13.8%) |
| Sep 2011 | - | $113.48M(-5.8%) |
| Jun 2011 | - | $120.51M(+8.2%) |
| Mar 2011 | - | $111.37M(-1.8%) |
| Dec 2010 | $113.44M(+22.0%) | $113.44M(+14.4%) |
| Sep 2010 | - | $99.12M(+4.2%) |
| Jun 2010 | - | $95.16M(-4.0%) |
| Mar 2010 | - | $99.16M(+6.6%) |
| Dec 2009 | $92.99M(-21.2%) | $92.99M(+0.7%) |
| Sep 2009 | - | $92.38M(+1.7%) |
| Jun 2009 | - | $90.85M(-5.3%) |
| Mar 2009 | - | $95.95M(-18.7%) |
| Dec 2008 | $117.98M(+22.3%) | $117.98M(+17.2%) |
| Sep 2008 | - | $100.63M(-1.7%) |
| Jun 2008 | - | $102.32M(+3.4%) |
| Mar 2008 | - | $98.93M(+2.5%) |
| Dec 2007 | $96.47M | $96.47M(+41.7%) |
| Sep 2007 | - | $68.10M(+1.3%) |
| Jun 2007 | - | $67.23M(+8.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2007 | - | $61.95M(-25.7%) |
| Dec 2006 | $83.41M(+14.3%) | $83.41M(+29.3%) |
| Sep 2006 | - | $64.51M(-6.9%) |
| Jun 2006 | - | $69.30M(+4.0%) |
| Mar 2006 | - | $66.64M(-8.6%) |
| Dec 2005 | $72.95M(+2.5%) | $72.95M(+7.2%) |
| Sep 2005 | - | $68.08M(-1.7%) |
| Jun 2005 | - | $69.25M(+3.1%) |
| Mar 2005 | - | $67.14M(-5.7%) |
| Dec 2004 | $71.19M(+31.9%) | $71.19M(+28.2%) |
| Sep 2004 | - | $55.52M(-17.5%) |
| Jun 2004 | - | $67.34M(+18.1%) |
| Mar 2004 | - | $57.03M(+5.6%) |
| Dec 2003 | $53.99M(-28.2%) | $53.99M(-10.8%) |
| Sep 2003 | - | $60.52M(+14.4%) |
| Jun 2003 | - | $52.89M(-33.1%) |
| Mar 2003 | - | $79.00M(+5.0%) |
| Dec 2002 | $75.23M(+15.9%) | $75.23M(+9.8%) |
| Sep 2002 | - | $68.50M(-1.3%) |
| Jun 2002 | - | $69.41M(+2.3%) |
| Mar 2002 | - | $67.85M(+4.5%) |
| Dec 2001 | $64.90M(+3.1%) | $64.90M(-4.3%) |
| Sep 2001 | - | $67.83M(+11.9%) |
| Jun 2001 | - | $60.62M(-2.3%) |
| Mar 2001 | - | $62.05M(-1.5%) |
| Dec 2000 | $62.97M(-2.7%) | $62.97M(+12.3%) |
| Sep 2000 | - | $56.08M(-5.1%) |
| Jun 2000 | - | $59.12M(-3.7%) |
| Mar 2000 | - | $61.40M(-5.1%) |
| Dec 1999 | $64.70M(+142.3%) | $64.70M(+190.1%) |
| Sep 1999 | - | $22.30M(-5.1%) |
| Jun 1999 | - | $23.50M(-8.6%) |
| Mar 1999 | - | $25.70M(-3.7%) |
| Dec 1998 | $26.70M(-17.6%) | $26.70M(+19.7%) |
| Sep 1998 | - | $22.30M(-10.8%) |
| Jun 1998 | - | $25.00M(-12.3%) |
| Mar 1998 | - | $28.50M(-12.0%) |
| Dec 1997 | $32.40M(+52.1%) | $32.40M(+16.5%) |
| Sep 1997 | - | $27.80M(+13.0%) |
| Jun 1997 | - | $24.60M(+23.6%) |
| Mar 1997 | - | $19.90M(-6.6%) |
| Dec 1996 | $21.30M(+7.0%) | $21.30M(+26.8%) |
| Sep 1996 | - | $16.80M(-13.8%) |
| Jun 1996 | - | $19.50M(+0.5%) |
| Mar 1996 | - | $19.40M(-2.5%) |
| Dec 1995 | $19.90M(-5.7%) | $19.90M(+8.2%) |
| Sep 1995 | - | $18.40M(-11.1%) |
| Jun 1995 | - | $20.70M(-14.1%) |
| Mar 1995 | - | $24.10M(+14.2%) |
| Dec 1994 | $21.10M(+43.5%) | $21.10M(+34.4%) |
| Sep 1994 | - | $15.70M(-5.4%) |
| Jun 1994 | - | $16.60M(+18.6%) |
| Mar 1994 | - | $14.00M(-4.8%) |
| Dec 1993 | $14.70M(-22.2%) | $14.70M(+14.8%) |
| Sep 1993 | - | $12.80M(-15.8%) |
| Jun 1993 | - | $15.20M(-16.5%) |
| Mar 1993 | - | $18.20M(-3.7%) |
| Dec 1992 | $18.90M(+8.0%) | $18.90M(+3.8%) |
| Sep 1992 | - | $18.20M(-2.2%) |
| Jun 1992 | - | $18.60M(-4.1%) |
| Mar 1992 | - | $19.40M(+10.9%) |
| Dec 1991 | $17.50M(-5.9%) | $17.50M(+15.9%) |
| Sep 1991 | - | $15.10M(-23.0%) |
| Jun 1991 | - | $19.60M(+12.6%) |
| Mar 1991 | - | $17.40M(-6.5%) |
| Dec 1990 | $18.60M(+12.0%) | $18.60M(+30.1%) |
| Sep 1990 | - | $14.30M(-0.7%) |
| Jun 1990 | - | $14.40M(-13.3%) |
| Mar 1990 | - | $16.60M(0.0%) |
| Dec 1989 | $16.60M | $16.60M(+25.8%) |
| Sep 1989 | - | $13.20M(+8.2%) |
| Jun 1989 | - | $12.20M |
FAQ
- What is Bio-Rad Laboratories annual accounts payable?
- What is the all time high annual accounts payable for Bio-Rad Laboratories?
- What is Bio-Rad Laboratories annual accounts payable year-on-year change?
- What is Bio-Rad Laboratories quarterly accounts payable?
- What is the all time high quarterly accounts payable for Bio-Rad Laboratories?
- What is Bio-Rad Laboratories quarterly accounts payable year-on-year change?
What is Bio-Rad Laboratories annual accounts payable?
The current annual accounts payable of BIO is $122.30M
What is the all time high annual accounts payable for Bio-Rad Laboratories?
Bio-Rad Laboratories all-time high annual accounts payable is $148.51M
What is Bio-Rad Laboratories annual accounts payable year-on-year change?
Over the past year, BIO annual accounts payable has changed by -$22.30M (-15.42%)
What is Bio-Rad Laboratories quarterly accounts payable?
The current quarterly accounts payable of BIO is $137.90M
What is the all time high quarterly accounts payable for Bio-Rad Laboratories?
Bio-Rad Laboratories all-time high quarterly accounts payable is $280.45M
What is Bio-Rad Laboratories quarterly accounts payable year-on-year change?
Over the past year, BIO quarterly accounts payable has changed by +$35.15M (+34.21%)